After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Bruker Corporation today announced the launch of the VERTEX NEO Platform today with its first product, the VERTEX NEO R. This ...

Good day and welcome to the Vertex Pharmaceuticals fourth quarter of 2024 earnings call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over ...

The Paris AI Action Summit, under the banner of ethical AI innovation, appears disconnected from the realities of how ...

Amazon is officially in the quick commerce arena, with its service available in parts of Bengaluru. This and more in today’s ETtech Morning Dispatch.

Vertex's candidate, called VX-548, targets NaV1.8 sodium channels, which are thought to play a role in relaying pain signals to the spinal cord from peripheral nerves. It has been shown to be ...

Google Gemini 2.0 AI is here! Discover the latest features and updates that make this release a game-changer for AI ...

Maia, as the AI bot is called, is the first of its kind here and takes only a 0.2% commission. Read more at straitstimes.com.

What does this have to do with the precious metals market? While this is not a direct reason for the precious metals market ...